Zhitong Finance APP reported that YSB (09885) announced that on January 6, 2025, according to the trust arrangement established between the company and the REITs (trustee), in order to satisfy the rewards granted under the Stock-based Incentive plan, the trustee will repurchase 0.1 million shares of the company in the market at a total price of 0.5665 million Hong Kong dollars, with an average price of 5.67 Hong Kong dollars per share. According to the trust arrangement, the trustee shall hold and manage the funds and properties (trust fund) in a trust manner for the benefit of eligible participants in accordance with the Stock-based Incentive plan and trust arrangement. The company may instruct the trustee to repurchase additional shares as needed and issue further voluntary announcements regarding the repurchase from time to time.

The Board of Directors believes that the company's current stock price is below its intrinsic value and may not adequately reflect the company's business prospects, thus providing a good opportunity for the trustee to repurchase the company's shares in the market to supplement the trust fund. At the same time, repurchasing shares under the Stock-based Incentive plan demonstrates the company's confidence in its business outlook and prospects, and also serves as part of the strategy to attract talent and align the interests of key employees with those of the company, promoting the long-term sustainable growth of the group. As the largest digital comprehensive service platform in China's outpatient pharmaceutical industry, we will continue to promote the healthy development of the industry through our efficient Internet pharmaceutical distribution network and medical Technology innovation methods, in line with the rapid development of the Digital Health industry and better fulfilling the mission of 'making good medicine and good drugs accessible to all.'